Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hormone replacement therapy may improve breast cancer detection and survival rate

13.09.2002


OHSU study suggests that HRT may act on cancer cells to produce less aggressive tumors



A study of nearly 300 breast cancer patients at Oregon Health & Science University found that women who use hormone replacement therapy (HRT) have less aggressive tumors and are more likely to be diagnosed through mammograms than other methods. Also, HRT users with breast cancer had significantly better survival rates than non-HRT users. The study is published in the September issue of the journal The Archives of Surgery.

Because hormones increase the density of breast tissue, researchers have suspected that HRT use would make it more difficult to detect tumors on mammograms. As a result, it was suspected that tumors in patients who have received HRT might not be detected until they were larger and more advanced. However, of 144 study patients using HRT, 84 had their tumors detected by mammogram, while 60 were detected by other methods. Comparatively, of 148 non-HRT users, 63 had their tumors detected by mammogram, while 85 were detected by palpation (feeling for lumps).


Even more surprising, among the women whose tumors were detected by mammogram, HRT users had a 100 percent survival rate, while nonusers had only an 87 percent survival rate after six years. The study found significantly fewer cases of invasive tumors among HRT users, and higher incidences of T1 lesions, stage 1 tumors and node-negative tumors--all signs of a less aggressive disease.

"From this data it appears that HRT use had only beneficial effects on breast cancer detection and outcomes, with no visible negative effects," said Rodney F. Pommier, M.D., associate professor of surgery in the OHSU School of Medicine and principal investigator of the study.

Hormone replacement therapy has come under fire in recent months after several studies indicated that long-term use of combination hormone therapies can lead to slight increases in heart disease, stroke and breast cancer among patients.

"Every woman should talk to her physician about her own risks and benefits of taking hormones," said Pommier. "But this data needs to be taken into consideration as well. If we know that HRT can improve survival rates by producing a less aggressive breast cancer, then it’s possible that by withholding HRT for the purpose of possibly preventing a few cases of breast cancer, you’re going to have a higher death rate among women who were going to get the disease anyway."

The Women’s Health Initiative last July canceled its clinical trial on the use of combination estrogen-progestin HRT due to higher reports of associated illnesses. However, there has not been the same association with estrogen-only HRT. The OHSU study, which was a retrospective analysis of patients already diagnosed with breast cancer, included patients who took any form of HRT.

"This study opens an entirely new direction for future research of breast cancers. When we learn how HRT favorably affects the biology of tumors we can then use that information in a therapeutic fashion to improve the outcome of women with breast cancer," said study co-investigator SuEllen Toth-Fejel, Ph.D., research assistant professor of surgery in the OHSU School of Medicine, who led the laboratory work on the project.

Martin Munguia | EurekAlert!
Further information:
http://www.ohsu.edu/

More articles from Health and Medicine:

nachricht 'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers
16.02.2018 | National University of Science and Technology MISIS

nachricht New process allows tailor-made malaria research
16.02.2018 | Eberhard Karls Universität Tübingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

Im Focus: Autonomous 3D scanner supports individual manufacturing processes

Let’s say the armrest is broken in your vintage car. As things stand, you would need a lot of luck and persistence to find the right spare part. But in the world of Industrie 4.0 and production with batch sizes of one, you can simply scan the armrest and print it out. This is made possible by the first ever 3D scanner capable of working autonomously and in real time. The autonomous scanning system will be on display at the Hannover Messe Preview on February 6 and at the Hannover Messe proper from April 23 to 27, 2018 (Hall 6, Booth A30).

Part of the charm of vintage cars is that they stopped making them long ago, so it is special when you do see one out on the roads. If something breaks or...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Fingerprints of quantum entanglement

16.02.2018 | Information Technology

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers

16.02.2018 | Health and Medicine

Hubble sees Neptune's mysterious shrinking storm

16.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>